Alternate Health News
News
0
Ticker
AHGIF
ISIN
CA02090B1022
Alternate Health Eulerpool News
Alternate Health Stock News
Alternate Health is being monitored by journalists and investors worldwide. We gather the latest Alternate Health news here.
Alternate Health Stock Press Releases
Alternate Health regularly publishes news on the company's website that are relevant for investors.
Alternate Health News 2026
This page contains all current news, analysis and press releases for Alternate Health stock (AHGIF, ISIN: CA02090B1022). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Alternate Health.
Alternate Health Stock
Alternate Health Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs.